Total raised
$10.7M
Last: Undisclosed 2010-11
Stage
Acquired
Founded
2006
Headcount
28
HQ
Modi'in-Maccabim-Re'ut
Sector
Health Tech & Life Sciences
About
Exalenz Bioscience develops and commercializes systems that extract vital information for diagnostics from subtle changes in patients' exhaled breath using the company's BreathID technology platform. The company's proprietary core technology enables medical specialists to easily identify and manage specific digestive and liver conditions while ensuring both clinical precision and patient comfort. The BreathID Hp is a clinically proven, easy, and accurate single-step urea breath test for diagnosing and monitoring H. pylori infection in adults.
Funding history · 1 round · $10.7M total
2010-11
Undisclosed
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesMedical Monitors
Target customers
Healthcare & Life SciencesHealthcareProvidersLaboratories
Business model
B2B
Highlights
1 Patents
Tags
bioconvergencegastroenterologydiagnosticsreal-timebacteriaulcersmedical-technologiesnon-invasivelaboratoriesdoctorsclinicshealthcare-providers